Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets.

Scientists and doctors say FDA’s endorsement without requiring large, randomized clinical trials leaves practitioners facing emotional pleas from families while lacking data, guidance or confidence to ...

If you want to get one of the best ones out there and save yourself a lot of cash in the process, then you’re going to want ...

Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the initiation of a new research and development ...

In today’s competitive job market, a promising offer can feel like a lifeline, especially for those actively seeking ...

() - One San Diego County supervisor is concerned about civilians posing as U.S. Immigration and Customs Enforcement agents using fake ICE clothing and tactical gear and sowing ...

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 ...

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological ...

Before you start training: Seeing the course, in person or online helps guide key elements of you training. In specific weeks ...

Ritedose receives FDA approval for Tobramycin Tobramycin expands nation's largest nebulized drug portfolio. - Generic ...

Key Takeaways - Artificial intelligence (AI) tools are accelerating risks of trademark infringement, dilution and genericness ...